RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
DiaSorin SpA Stock

DiaSorin SpA Market capitalization 2024

DiaSorin SpA Market capitalization

5.99 B EUR

Ticker

DIA.MI

ISIN

IT0003492391

WKN

A0MTB2

In 2024, DiaSorin SpA's market cap stood at 5.99 B EUR, a 17.67% increase from the 5.09 B EUR market cap in the previous year.

The DiaSorin SpA Market capitalization history

YEARMarket Capitalization (undefined EUR)
20235.52
20227.26
20219.68
20208.52
20195.38
20184.45
20173.69
20162.82
20152.19
20141.66
20131.63
20121.26
20111.6
20101.58
20091.04
20080.7
20070.64
2006-
2005-

DiaSorin SpA Aktienanalyse

What does DiaSorin SpA do?

DiaSorin SpA is an Italian medical technology company that specializes in the development and production of diagnostic solutions for serious diseases. The company was founded in 1968 in Saluggia, a small town in the Piedmont region of northern Italy. Since then, DiaSorin has experienced impressive growth and now operates worldwide. DiaSorin is a major player in the in-vitro diagnostics (IVD) market and offers a wide range of solutions for clinical laboratories and medical professionals. The company's business model is based on the development of innovative test systems that enable fast, reliable, and accurate diagnosis of diseases. The company's goal is to provide improved access to diagnostic opportunities for patients worldwide and support the entire medical practice. In its early days, DiaSorin mainly focused on the development and production of enzyme immunoassays (EIAs) and other immunochemical tests. However, over the years, the company has evolved and introduced a variety of product lines, including molecular diagnostic tests, automated immunoassay systems and instruments, and clinical laboratory software. Today, DiaSorin has four main business areas: Immunoassays, Molecular Biology, Automation, and Diagnosis Information Management. The Immunoassays business area, also known as diaMune, offers a wide range of immunoassay solutions based on various technologies, including chemiluminescence, ELISA, fluorescence, and multiplexing. The Molecular Biology business area, also known as DiaMolecular, develops and produces a broad spectrum of molecular diagnostic solutions, including tests for infectious diseases, oncological diseases, and genetic disorders. DiaMolecular's products provide fast, efficient, and highly accurate diagnosis of serious diseases, enabling early treatment and therapy. The third major business area, DiaSorin's automation solutions, offers instruments and automated testing systems that optimize laboratory processes, improve efficiency, and speed up test execution. These solutions not only increase the accuracy and reliability of diagnostic tests but also help reduce costs and workload in medical laboratories. Finally, DiaSorin's Diagnosis Information Management business area offers a variety of software solutions that assist medical professionals in managing and interpreting diagnostic data. These solutions enable faster and more accurate diagnosis and can also contribute to improving patient care and optimizing laboratory processes. DiaSorin is led by a strong and experienced management team committed to driving the company's growth through continuous innovation and expansion into new markets. With branches and subsidiaries around the world, DiaSorin is a key player in the global medical technology industry. Overall, DiaSorin is an innovative and forward-thinking company that continuously develops its technologies and solutions to improve the quality of life for millions of people worldwide. DiaSorin SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring DiaSorin SpA's Market Capitalization

DiaSorin SpA's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of DiaSorin SpA's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

DiaSorin SpA's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in DiaSorin SpA’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about DiaSorin SpA stock

What is the current DiaSorin SpA market capitalization?

The current market capitalization of DiaSorin SpA is 5.99 B EUR.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like DiaSorin SpA.

How has the market capitalization of DiaSorin SpA developed in recent years?

The market capitalization of DiaSorin SpA has increased/decreased by 17.67% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of DiaSorin SpA?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of DiaSorin SpA?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of DiaSorin SpA have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does DiaSorin SpA pay?

Over the past 12 months, DiaSorin SpA paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 1.02 %. For the coming 12 months, DiaSorin SpA is expected to pay a dividend of 1.24 EUR.

What is the dividend yield of DiaSorin SpA?

The current dividend yield of DiaSorin SpA is 1.02 %.

When does DiaSorin SpA pay dividends?

DiaSorin SpA pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of DiaSorin SpA?

DiaSorin SpA paid dividends every year for the past 0 years.

What is the dividend of DiaSorin SpA?

For the upcoming 12 months, dividends amounting to 1.24 EUR are expected. This corresponds to a dividend yield of 1.15 %.

In which sector is DiaSorin SpA located?

DiaSorin SpA is assigned to the 'Health' sector.

Wann musste ich die Aktien von DiaSorin SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DiaSorin SpA from 5/22/2024 amounting to 1.15 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did DiaSorin SpA pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of DiaSorin SpA in the year 2023?

In the year 2023, DiaSorin SpA distributed 1.05 EUR as dividends.

In which currency does DiaSorin SpA pay out the dividend?

The dividends of DiaSorin SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von DiaSorin SpA

Our stock analysis for DiaSorin SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DiaSorin SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.